Regular Article
β-Amyloid Peptide Expression Is Sufficient for Myotube Death: Implications for Human Inclusion Body Myopathy

https://doi.org/10.1006/mcne.2001.0972Get rights and content

Abstract

Inclusion body myositis (sIBM) is the most common disorder of skeletal muscle in aged humans. It shares biochemical features with Alzheimer's disease, including congophilic deposits, which are immunoreactive for β-amyloid peptide (Aβ) and C′-terminal βAPP epitopes. However, the etiology of myofiber loss and the role of intracellular Aβ in IBM is unknown. Here we report correlative evidence for apoptotic cell death in myofibers of IBM patients that exhibit pronounced Aβ deposition. HSV-1-mediated gene transfer of Aβ42 into cultured C2C12 myotubes resulted in a 12.6-fold increase in dUTP-labeled and condensed nuclei over nonexpressing myotubes (P < 0.05). The C′-terminal βAPP domain C99 also induced myotube apoptosis, but to a significantly lesser extent than Aβ. Apoptosis specific to Aβ-expressing myotubes was also demonstrated through DNA fragmentation, decreased mitochondrial function and the loss of membrane phospholipid polarity. Myotubes laden with Aβ42, but not other transgene products, developed cytoplasmic inclusions consisting of fibrillar material. Furthermore, injection of normal mouse gastrocnemius muscle with HSV-encoding Aβ cDNA resulted in TUNEL-positive myofibers with pyknotic nuclei. We conclude that Aβ is sufficient to induce apoptosis in myofibers both in vivo and in vitro and suggest it may contribute to myofiber loss and muscle dysfunction in patients with IBM.

References (73)

  • M. Olive et al.

    Bcl-2 and Bax protein expression in human myopathies

    J. Neurol. Sci.

    (1999)
  • F. Saudou et al.

    Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with formation of intranuclear inclusions

    Cell

    (1998)
  • A. Sawa et al.

    Aberrant expression of bcl-2 gene family in Down's syndrome brains

    Brain Res. Mol. Brain Res.

    (1997)
  • G. Smale et al.

    Evidence for apoptotic cell death in Alzheimer's disease

    Exp. Neurol.

    (1995)
  • B. Sopher et al.

    Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the β-amyloid precursor protein

    Mol. Brain Res.

    (1994)
  • P. Walker et al.

    Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis

    Exp. Cell. Res.

    (1994)
  • C. Wellington et al.

    Caspace cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract

    J. Biol. Chem.

    (1998)
  • C. Wild-Bode et al.

    Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42

    J. Biol. Chem.

    (1997)
  • N. Zheng et al.

    Signal Sequences: The same yet different

    Cell

    (1996)
  • V. Andrés et al.

    Myogenin expression, cell cycle withdrawal and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis

    J. Cell Biol.

    (1996)
  • V. Askanas et al.

    β-Amyloid precursor epitopes in muscle fibers of inclusion body myositis

    Ann. Neurol.

    (1993)
  • V. Askanas et al.

    Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis

    Ann. Neurol.

    (1996)
  • V. Askanas et al.

    Sporadic inclusion-body myositis and hereditary inclusion-body myopathies

    Arch. Neurol.

    (1998)
  • V. Askanas et al.

    New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies

    Curr. Opin. Rheumatol.

    (1995)
  • V. Askanas et al.

    Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis

    Am. J. Pathol.

    (1992)
  • V. Askanas et al.

    Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau

    Am. J. Pathol.

    (1994)
  • R. Barohn et al.

    Inclusion body myositis: Explanation for poor response to immunosuppressive therapy

    Neurology

    (1995)
  • P. Baron et al.

    Synergistic effect of β-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells

    Brain

    (2000)
  • L. Behrens et al.

    Cytotoxic mechanisms in inflammatory myopathies

    Brain

    (1997)
  • W. Bursch et al.

    Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats

    Carcinogenesis

    (1990)
  • S. Bursztajn et al.

    Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer's disease mutant does not enhance apoptosis

    J. Neurosci.

    (1998)
  • D. Cook et al.

    Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

    Nature Med.

    (1997)
  • D. Figarella-Branger et al.

    Inclusion body myositis: Pathologic changes

  • G. Forloni et al.

    Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35

    NeuroReport

    (1993)
  • I.-M. Fyhr et al.

    Upregulation of Fas/Fas ligand in inclusion body myositis

    Ann. Neurol.

    (1998)
  • G. Giaccone et al.

    βPP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease

    Am. J. Pathol.

    (1996)
  • Cited by (40)

    • Detection of Aβ-interacting proteins via a novel Aβ-adsorbents that use immobilized regular comb polymer

      2014, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
      Citation Excerpt :

      Aβ is the main component of amyloid plaques in the brains of AD patients. Similar Aβ plaques are also found in some variants of Lewy body dementia [7] and inclusion body myositis [8]. Furthermore, Aβ aggregates can coat cerebral blood vessels in cerebral amyloid angiopathy [9].

    • Foxo/Atrogin induction in human and experimental myositis

      2012, Neurobiology of Disease
      Citation Excerpt :

      Necrosis and inflammation are generally more pronounced in PM. Muscle myofiber apoptosis, whether nonexistent (Nagaraju et al., 2000; Schneider et al., 1996) or present but rare in sIBM and hereditary (h)IBM (Hutchinson, 1998; Querfurth et al., 2001; Yan et al., 2001) cannot account for the loss. Yet, the possibility that the extent of apoptosis in degenerative muscle diseases is underrated has been raised (Amsili et al., 2007; Tews, 2002).

    • Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy

      2012, Journal of Biological Chemistry
      Citation Excerpt :

      However, hyposialylation of NEP, a catabolic enzyme for Aβ peptides, has been hypothesized to cause disturbance of amyloid metabolism at least in DMRV/hIBM (26). As amyloid deposits within myofibers precede the occurrence of rimmed vacuoles and muscle degeneration in DMRV/hIBM mice (18) and amyloid has been shown to exert toxicity in muscle cells (44), the NEP hypothesis may be a reasonable platform to explain the pathomechanism of DMRV/hIBM on the basis of hyposialylation and its effect on the progression of the disease. In this study, we demonstrated that NEP is hyposialylated and has reduced enzyme activity, and this occurs together with the increase in the amyloid burden within skeletal muscles in symptomatic DMRV/hIBM mice.

    • Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

      2009, Alzheimer's and Dementia
      Citation Excerpt :

      The cholinergic neuromuscular junctions of skeletal muscle are another potentially rich source of Aβ peptides [2,60,61]. The production of Aβ peptides is exacerbated in inclusion body myositis, the most common skeletal muscle inflammatory disease among the elderly [61–63]. Our studies revealed significant differences in Aβ42 and total Aβ between AD and ND control populations.

    • Amyloid toxicity in skeletal myoblasts: Implications for inclusion-body myositis

      2008, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      IBM is a debilitating disorder, its diagnostic method and molecular basis of pathogenesis remains poorly defined. It has been previously reported that cytotoxicity of overexpressed β-amyloid in cultured skeletal muscle fibers [56]. Increased amount of deposition of multiple subfragments of β-amyloid precursor protein as amyloid aggregates were observed in muscle fibers from IBM biopsies [57].

    • Inclusion body myositis

      2008, Revue du Rhumatisme (Edition Francaise)
    View all citing articles on Scopus
    1

    To whom correspondence and reprint requests should be addressed. Fax: (617) 789-5177. E-mail: [email protected].

    View full text